Denise Peterson

My comrade Brenda Sandburg several years ago profiled pioneering photojournalist Betty Steele, who died recently. Here’s an short – and wonderful – clip of Brenda interviewing Betty. Inspiring.

Brenda Sandburg @brendasandburg

https://t.co/bns7MmA5D6 This clip shows some of Betty's amazing photos.

RT @KFFHealthNews: Join host @jrovner and panelists @shefalil, @SarahKarlin, and @AliceOllstein for a new health-packed ep. of #WTHealth! T…

My TrialScope colleagues are benchmarking how biopharmas balance clinical trial reporting compliance/transparency with redacting sensitive company & patient data. If you’re involved in this area, help us out by taking this brief confidential survey: https://t.co/Y1dRmzmXzI

RT @SarahKarlin: More on the House Republican drug shortage bill this came from, from me last week: https://t.co/L8lZWQ0g8F

Thomas Wicks, a Citeline colleague & trial transparency SME, is benchmarking how pharma is balancing transparency with needs to redact or anonymize some data. Help us out with our survey. #clinicaltrials #redaction #transparency https://t.co/u8H5n9BVU3

RT @PinkSheetSutter: A handy, quick reference for tracking industry lawsuits over the IRA's drug price negotiation provisions https://t.co…

RT @ScripRegVibha: Saudi FDA’s membership to PIC/s means that it can become a reference authority for inspecting pharmaceutical factories,…

RT @PinkSheetSutter: Wow - only 6 voting members on panel, 2 of whom are regular members of the PCNSDAC. In all my many many years of cover…

RT @SarahKarlin: Our first day #BIO2023 notefrom from me, @ScripMandy and Kevin Grogan. https://t.co/8c8PXVRlr8

RT @dgingery: (2/2) And here is @PinkSheetSutter's look at Pepaxto from the FDA perspective ... #PinkSheet #pharma: https://t.co/1iKZmCxn3y

RT @dgingery: (1/2) An interesting look at the saga of Pepaxto from our @ScripFrancesca and @PinkSheetSutter today. This is Francesca's loo…

RT @dgingery: More supplemental filings from me and @SarahKarlin ... #pinksheet #pharma: Supplemental Filings: Pink Sheet Notebook On Disea…

RT @PinkSheetSutter: Our quick hit on the Makena situation https://t.co/0q4iVq3hKU

RT @dgingery: Our take on yesterday's big neurology news from @PinkSheetSutter ... #pinksheet #pharma: @US_FDA Neuroscience Office Director…

RT @dgingery: My analysis of the new OPT org chart ... #Pinksheet #Pharma: CBER’s New Home For Gene Therapies: OTAT Changes To OTP But Lead…

RT @PinkSheetSutter: “We have these big societal issues and the decision about an individual product is like the tip of the spear of someth…

Our job opening for a Disclosure Regulations Research Manager is great for someone keen on the intersection of regulatory policy, clinical trials and patient engagement. More in our ad: https://t.co/J3v7mmz1mF